The impact of COVID-19 second wave on a majority of Indian corporates is "manageable", market analyst Fitch Ratings Inc said on May 31. The fallout on the private sector is not as worse as seen in the same period during 2020, it said.
The reasons behind businesses surviving the worst brunt of the pandemic, claims Fitch, is due to the imposition of "localised" lockdowns rather than a blanket shutdown, and the adjustments made by corporates in accordance with the restrictions.
"We believe the second wave will have a less severe impact on corporates than in 2020, despite a higher infection rate. Weaker domestic demand is a key channel of risk transmission for businesses. However, lockdowns in 2021 have been less stringent and more localised, and business/societal behaviour has adjusted, supporting activity," said a release issued by Fitch.
The impact of the second wave on the majority of India's "rated corporate universe is expected to be manageable", the American credit rating agency noted.
The credit profiles of most companies are "being supported by their strong market positions, adequate balance sheets and liquidity, diversified operations and/or flexibility to adjust costs and key business drivers, until operations recover with the easing of restrictions", it added.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
There are, however, several entities with low rating headroom or which could be subject to negative rating action if India’s sovereign rating (BBB-/Negative) or Country Ceiling (BBB-) were downgraded, Fitch said.
The agency predicts the "greatest demand impact" within its rated portfolio to be felt by Oravel Stays Private Limited (OYO, B(EXP)/Negative) and Future Retail Limited (RD), "as weak consumer sentiment affects discretionary spending in fields like hospitality and non-food retail".
Technology and telecom companies are the least likely to see weaker demand, it added.
"Falling demand for diesel and gasoline will hit throughput at refining companies, but stronger refining and marketing margins will aid their profitability," Fitch further said.
For the power sector, the agency expects lower curtailment risk for domestic producers than in 2020. However, further delays in payments from state-owned power distribution companies (discoms) "could weaken cash flows and liquidity", it warned.
Similarly, the construction sector could be hit by "execution delays in construction projects", the agency said. This could affect demand for building materials and steel, Fitch claimed, but added that the activity in this sector is expected "to pick up once the current (COVID-19) wave subsides".The improvement in the COVID-19 situation across the world would also directly improve the "global demand" for sectors like steel, chemicals and pharmaceuticals, Fitch suggested.